Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/31/1995EP0654992A1 Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
05/31/1995EP0574433B1 6,9-BIS(AMINO SUBSTITUTED)BENZO g]PHTHALAZINE-5,10-DIONES AS ANTITUMOR AGENTS
05/31/1995EP0573467B1 NEUROLEPTIC PERHYDRO-1H-PYRIDO 1,2-a]PYRAZINES
05/31/1995EP0542912B1 Calcium and trace mineral supplements
05/31/1995EP0515462B1 Indole derivatives, their preparation and use
05/31/1995EP0465520B1 Sugar composition comprising soluble fibre
05/31/1995CN1102981A Ferric selenium injection for animal
05/31/1995CN1102980A Soluble kanamycin powder for poultry
05/31/1995CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound
05/31/1995CN1028640C 1,4-diazepine derivative and its pharmaceutical use
05/31/1995CN1028639C Improvements in and relating to leukotriene antagonists
05/31/1995CN1028638C Method for preparation of isoquinoline amides of sulphonic acids derivatives
05/31/1995CA2136936A1 Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
05/30/1995USRE34960 Carbapenem compounds, and compositions containing them
05/30/1995US5420350 Germicides
05/30/1995US5420339 Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
05/30/1995US5420335 Intravenous feeding
05/30/1995US5420334 Cyclohexanone or cyclohexanol derivatives
05/30/1995US5420333 Lignan analogues, methods of preparation thereof and anti-hyperlipemic agents
05/30/1995US5420319 Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same
05/30/1995US5420310 Conversion of 15-beta to 15-alpha 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives
05/30/1995US5420301 Process for the preparation of substituted difluorobenzo-1,3-dioxoles
05/30/1995US5420298 Pyrrolidine derivatives
05/30/1995US5420296 Angiogenesis inhibitors and cardiovascular disorders
05/30/1995US5420292 Biphenyl-tetrazole intermediate compounds
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420277 Intermediates for the preparation of heteroaryl derivatives of monocyclic beta-lactam antiobiotics
05/30/1995US5420273 Condensed heterocyclic compounds
05/30/1995US5420272 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
05/30/1995US5420163 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals
05/30/1995US5420162 Phorbol ester pharmaceutical compositions and their use for treating inflammation
05/30/1995US5420161 Doisynolic acid type compounds as weight and appetite suppressing and control agents
05/30/1995US5420158 Melatonin activity
05/30/1995US5420157 Anticancer agents
05/30/1995US5420156 Antidepressants an anxiolytic agents
05/30/1995US5420154 Administering a 2-pyrrolidinone derivative to an animal suffering from a tumor necrosis factor mediated disease
05/30/1995US5420152 Melatonin
05/30/1995US5420151 Serotonin antagonists
05/30/1995US5420150 Antidepressants and treatment of anxiety
05/30/1995US5420149 Imidazolyl-substituted phenylacetamides
05/30/1995US5420147 Benzimidazoles, benzotriazoles, controlling metabolism of retinoids, skin cancer
05/30/1995US5420146 Di-oxadiazolidine derivatives as antihyperglycemic agents
05/30/1995US5420143 Piperidine derivatives for treating allergy
05/30/1995US5420142 For treatment of cardiovascular conditions which require an increase in contractility of the heart
05/30/1995US5420141 Capable of binding to neurotensin receptor
05/30/1995US5420140 Difluorinated quinolones useful for treating bacterial infections
05/30/1995US5420139 Method for treatment of depression
05/30/1995US5420138 Bicyclic pyridines which are angiotensin II inhibitors
05/30/1995US5420135 Substituted quinoline derivatives
05/30/1995US5420134 Substituted hexahydrobenzo[A]phenanthridines
05/30/1995US5420133 Treating cardiovascular disorders
05/30/1995US5420132 Substituted benzodioxins
05/30/1995US5420131 Platelet activating factor antagonist or 5-lipoxygenase inhibitors
05/30/1995US5420130 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics
05/30/1995US5420129 Treatment of hypertension, ischemia, vasospasms, angina
05/30/1995US5420127 Morpholino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/30/1995US5420122 3-pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid compounds
05/30/1995US5420121 Use of 4-cholesten-3-one as an anti-obesity agent
05/30/1995US5420120 Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
05/30/1995US5420119 Carbapenem derivatives having antibiotic activity, their preparation and their use
05/30/1995US5420118 Gel type cosmetic compositions
05/30/1995US5420116 Pharmaceutical compositions for the treatment of disorders of the respiratory tract
05/30/1995US5420115 Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
05/30/1995US5420107 Method and composition for energy source supplementation during exercise and recovery
05/30/1995US5420106 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
05/30/1995US5419915 Medicament with an analgesic, antipyretic and/or antiphlogistic action and use of 2-ethoxybenzoic acid
05/30/1995US5419913 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
05/30/1995US5419912 Adhesive patch for percutaneous delivery of isosorbide dinitrate
05/30/1995US5419910 Growth promoters for animals
05/30/1995US5419908 Sanitizing composition comprising a blend of aromatic and polyunsaturated carboxylic acids
05/30/1995US5419898 Antiallergic composition for ophthalmic or nasal use
05/30/1995US5419897 Cationic polymers
05/30/1995US5419894 Complexing agents, complexes and complex salts
05/30/1995CA2136712A1 Piperazine derivatives
05/30/1995CA2066525C Synergistic combinations in the treatment of anxiety
05/30/1995CA2048235C Lowering of blood uric acid levels
05/30/1995CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
05/30/1995CA1335733C 1h-indazole-3-acetic acids as aldose reductase inhibitors
05/30/1995CA1335716C Methods for increasing extracellular adenosine and for stabilizing mast cells
05/30/1995CA1335714C Fluorocarbon emulsions having saturated phospholipid emulsifiers
05/27/1995CA2136669A1 1,3,4-oxadiazol-2(3h)-one derivatives, their preparation and their therapeutic application
05/26/1995WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014031A1 Chirally enriched synthetic phosphonate oligomers
05/26/1995WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995WO1995014026A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
05/26/1995WO1995014025A1 Piperidinylcamphorsulfonyl oxytocin antagonists
05/26/1995WO1995014023A1 Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
05/26/1995WO1995014022A1 NEW PIRROLO [3,2-e]INDOL DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/26/1995WO1995014020A1 IMIDAZO[1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995014016A1 Prodrugs of an inhibitor of hiv protease
05/26/1995WO1995014014A2 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014013A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014012A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014011A2 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995WO1995014007A1 Phenyl-alkyl imidazoles as h3-receptor antagonists